Marker-free characterization of full-length transcriptomes of single live circulating tumor cells
- Sarita Poonia1,
- Anurag Goel1,
- Smriti Chawla1,
- Namrata Bhattacharya2,
- Priyadarshini Rai1,
- Yi Fang Lee3,
- Yoon Sim Yap4,
- Jay West5,
- Ali Asgar Bhagat6,
- Juhi Tayal7,
- Anurag Mehta7,
- Gaurav Ahuja1,
- Angshul Majumdar1,
- Naveen Ramalingam1 and
- Debarka Sengupta1,8
- 1 Indraprastha Institute of Information Technology-Delhi;
- 2 Indraprastha Institute of Information Technology-Delhi, Queensland University of Technology;
- 3 Thermo Fisher Scientific;
- 4 National Cancer Centre Singapore;
- 5 Fluidigm Corporation;
- 6 National University of Singapore;
- 7 Rajiv Gandhi Cancer Institute and Research Centre
Abstract
The identification and characterization of circulating tumor cells (CTCs) are important for gaining insights into the biology of metastatic cancers, monitoring disease progression, and medical management of the disease. The limiting factor in the enrichment of purified CTC populations is their sparse availability, heterogeneity, and altered phenotypes relative to the primary tumor. Intensive research both at the technical and molecular fronts led to the development of assays that ease CTC detection and identification from peripheral blood. Most CTC detection methods based on single-cell RNA sequencing (scRNA-seq) use a mix of size selection, marker-based white blood cells (WBC) depletion, and antibodies targeting tumor-associated antigens. However, the majority of these methods either miss atypical CTCs or suffer from WBC contamination. We present unCTC, an R package for unbiased identification and characterization of CTCs from single-cell transcriptomic data. unCTC features many standard and novel computational and statistical modules for various analyses. These include a novel method of scRNA-seq clustering, named Deep Dictionary Learning using k-means clustering cost (DDLK), expression-based copy number variation (CNV) inference, and combinatorial, marker-based verification of the malignant phenotypes. DDLK enables robust segregation of CTCs and WBCs in the pathway space, as opposed to the gene expression space. We validated the utility of unCTC on scRNA-seq profiles of breast CTCs from six patients, captured and profiled using an integrated ClearCell FX and Polaris workflow that works by the principles of size-based separation of CTCs and marker-based WBC depletion.
- Received January 16, 2022.
- Accepted November 10, 2022.
- Published by Cold Spring Harbor Laboratory Press
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see https://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.











